Before revision: In addition, MIMS Ireland contains a preliminary section which each month includes: Extended monographs of new products that have become available in that month New Clinical Evidence (reviews of recently published/presented results of clinical trials) A Clinical Special (monthly focus on a particular condition) A monthly update on safety issues provided to MIMS Ireland by the Irish Authority for Pharmacovigilance reporting (the Irish Medicines Board, or IMB) A summary of the World Anti-Doping Agency (WADA) Code provided to MIMS Ireland by the Irish Sports Council Though MIMS Ireland is supported by advertisement and educational grants from the pharmaceutical industry, it is an independently written publication with a content and editorial policy left at the discretion of the editor .
After revision: In addition, MIMS Ireland contains a preliminary section which each month includes: Extended monographs of new products that have become available in that month New Clinical Evidence (reviews of recently published/presented results of clinical trials) A Clinical Special (monthly focus on a particular condition) A monthly update on safety issues provided to MIMS Ireland by the Irish Authority for Pharmacovigilance reporting (the Irish Medicines Board, or IMB) A summary of the World Anti-Doping Agency (WADA) Code provided to MIMS Ireland by the Irish Sports Council Though MIMS Ireland is supported by advertisement and educational grants from the pharmaceutical industry, it is an independently written and edited .